Variant report

Variant	esv2762943
Chromosome Location	chr19:35846150-35861848
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:198)
CpG islands
(count:366)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:198 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr19:35849261-35849449	K562	blood:	n/a	n/a
2	BACH1	chr19:35851866-35852079	K562	blood:	n/a	n/a
3	BATF	chr19:35845861-35846177	GM12878	blood:	n/a	n/a
4	BATF	chr19:35845812-35846219	GM12878	blood:	n/a	n/a
5	BCL3	chr19:35845771-35846177	GM12878	blood:	n/a	n/a
6	BHLHE40	chr19:35845830-35846158	GM12878	blood:	n/a	n/a
7	CEBPB	chr19:35849027-35849357	HepG2	liver:	n/a	chr19:35849192-35849203
8	CEBPB	chr19:35861291-35861545	IMR90	lung:	n/a	chr19:35861400-35861411
9	CEBPB	chr19:35849025-35849368	K562	blood:	n/a	chr19:35849192-35849203
10	CEBPB	chr19:35849017-35849385	IMR90	lung:	n/a	chr19:35849192-35849203
11	CEBPB	chr19:35861320-35861547	K562	blood:	n/a	chr19:35861400-35861411
12	CEBPB	chr19:35849039-35849353	Hela-S3	cervix:	n/a	chr19:35849192-35849203
13	CEBPB	chr19:35861294-35861521	HepG2	liver:	n/a	chr19:35861400-35861411
14	CEBPB	chr19:35861266-35861524	A549	lung:	n/a	chr19:35861400-35861411
15	CEBPB	chr19:35849037-35849249	K562	blood:	n/a	chr19:35849192-35849203
16	CEBPB	chr19:35849029-35849356	A549	lung:	n/a	chr19:35849192-35849203
17	CEBPB	chr19:35849083-35849292	H1-hESC	embryonic stem cell:	n/a	chr19:35849192-35849203
18	CHD2	chr19:35845832-35846195	GM12878	blood:	n/a	n/a
19	CTCF	chr19:35849891-35850044	NHEK	skin:	n/a	n/a
20	CTCF	chr19:35849940-35850021	MCF-7	breast:	n/a	n/a
21	CTCF	chr19:35849820-35849970	GM12868	blood:	n/a	n/a
22	CTCF	chr19:35849820-35849970	A549	lung:	n/a	n/a
23	CTCF	chr19:35849862-35850049	Fibrobl	skin:	n/a	n/a
24	CTCF	chr19:35849874-35849999	Hela-S3	cervix:	n/a	n/a
25	CTCF	chr19:35849840-35849990	GM12868	blood:	n/a	n/a
26	CTCF	chr19:35849798-35850068	GM13977	blood:	n/a	n/a
27	CTCF	chr19:35849820-35849970	GM12864	blood:	n/a	n/a
28	CTCF	chr19:35849894-35849995	MCF-7	breast:	n/a	n/a
29	CTCF	chr19:35849884-35850025	HepG2	liver:	n/a	n/a
30	CTCF	chr19:35849780-35849930	SK-N-SH_RA	brain:	n/a	n/a
31	CTCF	chr19:35849868-35850029	A549	lung:	n/a	n/a
32	CTCF	chr19:35846931-35847196	K562	blood:	n/a	chr19:35847066-35847084
33	CTCF	chr19:35849840-35849990	GM06990	blood:	n/a	n/a
34	CTCF	chr19:35847027-35847179	K562	blood:	n/a	chr19:35847066-35847084
35	CTCF	chr19:35849760-35849910	GM12874	blood:	n/a	n/a
36	CTCF	chr19:35849820-35849970	GM12869	blood:	n/a	n/a
37	CTCF	chr19:35849819-35849993	H1-hESC	embryonic stem cell:	n/a	n/a
38	CTCF	chr19:35849857-35850020	GM10248	blood:	n/a	n/a
39	CTCF	chr19:35849840-35849990	GM12866	blood:	n/a	n/a
40	CTCF	chr19:35849824-35850062	K562	blood:	n/a	n/a
41	CTCF	chr19:35849780-35849930	HMEC	breast:	n/a	n/a
42	CTCF	chr19:35847000-35847150	GM06990	blood:	n/a	chr19:35847066-35847084
43	CTCF	chr19:35849907-35849974	MCF-7	breast:	n/a	n/a
44	CTCF	chr19:35849882-35849979	MCF-7	breast:	n/a	n/a
45	CTCF	chr19:35849864-35850076	Spleen_OC	spleen:	n/a	n/a
46	CTCF	chr19:35850172-35850235	GM12891	blood:	n/a	n/a
47	CTCF	chr19:35849861-35850024	ProgFib	skin:	n/a	n/a
48	CTCF	chr19:35849780-35849930	GM12875	blood:	n/a	n/a
49	CTCF	chr19:35849682-35849801	Lung_OC	lung:	n/a	n/a
50	CTCF	chr19:35846962-35847134	HepG2	liver:	n/a	chr19:35847066-35847084

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:35846383-35846433	PANC-1	pancreas:	n/a
2	chr19:35846383-35846433	MCF10A-Er-Src	breast:	n/a
3	chr19:35846383-35846433	SK-N-SH	brain:	n/a
4	chr19:35850463-35850513	HCF	heart:	n/a
5	chr19:35849393-35849443	HCM	heart:	n/a
6	chr19:35849393-35849443	PrEC	prostate:	n/a
7	chr19:35846383-35846433	ovcar-3	ovarian:	n/a
8	chr19:35849393-35849443	HRCEpiC	kidney:	n/a
9	chr19:35849176-35849226	SK-N-MC	brain:	n/a
10	chr19:35846383-35846433	HRPEpiC	eye:	n/a
11	chr19:35846383-35846433	NB4	blood:	n/a
12	chr19:35849176-35849226	CMK	blood:	n/a
13	chr19:35846383-35846433	HMEC	breast:	n/a
14	chr19:35846383-35846433	SKMC	muscle:	n/a
15	chr19:35849024-35849074	HL-60	blood:	n/a
16	chr19:35849176-35849226	HPAEpiC	pulmonary alveolar:	n/a
17	chr19:35846383-35846433	PrEC	prostate:	n/a
18	chr19:35846383-35846433	ECC-1	luminal epithelium:	n/a
19	chr19:35849024-35849074	AG09319	gingival:	n/a
20	chr19:35849393-35849443	AG04450	lung:	fetal
21	chr19:35850463-35850513	PFSK-1	brain:	n/a
22	chr19:35846383-35846433	AoSMC	blood vessel:	n/a
23	chr19:35849024-35849074	HEEpiC	esophagus:	n/a
24	chr19:35850463-35850513	HNPCEpiC	eye:	n/a
25	chr19:35849176-35849226	HEK293	kidney:	embryo
26	chr19:35848801-35848851	NHBE	bronchial:	n/a
27	chr19:35848801-35848851	ProgFib	skin:	n/a
28	chr19:35846383-35846433	U87	brain:	n/a
29	chr19:35850463-35850513	GM19239	blood:	n/a
30	chr19:35848801-35848851	HMEC	breast:	n/a
31	chr19:35849393-35849443	HAEpiC	amniotic membrane:	n/a
32	chr19:35849393-35849443	HEEpiC	esophagus:	n/a
33	chr19:35849024-35849074	K562	blood:	n/a
34	chr19:35849024-35849074	HCF	heart:	n/a
35	chr19:35849393-35849443	Hepatocyte	liver:	n/a
36	chr19:35846383-35846433	HEK293	kidney:	embryo
37	chr19:35846383-35846433	AG09309	skin:	n/a
38	chr19:35849176-35849226	AG10803	skin:	n/a
39	chr19:35850463-35850513	HCM	heart:	n/a
40	chr19:35849176-35849226	PANC-1	pancreas:	n/a
41	chr19:35848801-35848851	HRE	kidney:	n/a
42	chr19:35850463-35850513	IMR90	lung:	fetal
43	chr19:35848801-35848851	HAEpiC	amniotic membrane:	n/a
44	chr19:35848801-35848851	H1-hESC	embryonic stem cell:	embryo
45	chr19:35849393-35849443	HEK293	kidney:	embryo
46	chr19:35846383-35846433	HCT-116	colon:	n/a
47	chr19:35850463-35850513	NHDF-neo	bronchial:	n/a
48	chr19:35850463-35850513	NB4	blood:	n/a
49	chr19:35850463-35850513	HUVEC	blood vessel:	n/a
50	chr19:35846383-35846433	HRCEpiC	kidney:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:35842321..35845191-chr19:35845202..35847710,3	MCF-7	breast:
2	chr19:35842803..35847555-chr19:35958346..35962291,5	MCF-7	breast:
3	chr19:35847716..35849933-chr19:35855045..35856568,2	MCF-7	breast:

No data

Variant related genes	Relation type
FFAR3	TF binding region
GPR42	TF binding region
FFAR3	CpG island
GPR42	CpG island
ENSG00000185897	chromatin interactions
ENSG00000126266	chromatin interactions

Extended variants
information (count: 507 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:507 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs35470024	chr19:35846152-35846153	Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs569227913	chr19:35846166-35846167	Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs368991465	chr19:35846228-35846229	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs371548106	chr19:35846229-35846230	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs555009864	chr19:35846247-35846248	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs139457794	chr19:35846256-35846257	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs56026237	chr19:35846260-35846261	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs568324792	chr19:35846294-35846295	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs572370705	chr19:35846346-35846347	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs571467819	chr19:35846384-35846385	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs186710179	chr19:35846421-35846422	Enhancers Weak transcription Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs149983229	chr19:35846434-35846435	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs199793286	chr19:35846436-35846437	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs553985299	chr19:35846481-35846482	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs576997600	chr19:35846495-35846496	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs545873428	chr19:35846498-35846499	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs191166809	chr19:35846503-35846504	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs564274727	chr19:35846540-35846541	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs377290316	chr19:35846544-35846545	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs375413049	chr19:35846589-35846590	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs145153541	chr19:35846592-35846593	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs543654376	chr19:35846609-35846610	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs116050099	chr19:35846618-35846619	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs574764823	chr19:35846632-35846633	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs540554481	chr19:35846653-35846654	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs552647188	chr19:35846659-35846660	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs182534118	chr19:35846677-35846678	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs186855826	chr19:35846682-35846683	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs552640291	chr19:35846731-35846732	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs562797865	chr19:35846875-35846876	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs12462800	chr19:35846876-35846877	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs369660134	chr19:35846892-35846893	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs113324784	chr19:35846950-35846951	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs529446844	chr19:35846971-35846972	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs148386934	chr19:35847031-35847032	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs568493182	chr19:35847032-35847033	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs534063234	chr19:35847033-35847034	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs117676492	chr19:35847052-35847053	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs417030	chr19:35847075-35847076	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs192891361	chr19:35847083-35847084	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs387083	chr19:35847115-35847116	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
42	rs58080791	chr19:35847141-35847142	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs10422744	chr19:35847153-35847154	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs576022633	chr19:35847180-35847181	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs535196316	chr19:35847187-35847188	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs554922115	chr19:35847196-35847197	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs552195247	chr19:35847200-35847201	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs34849663	chr19:35847202-35847203	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs141413010	chr19:35847220-35847221	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs12462859	chr19:35847224-35847225	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	21397856	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Myelofibrosis	22110671	CNVD
Liver carcinoma	19366792	CNVD
Ovarian cancer	20844748	CNVD
Non-small cell lung cancer	21829676	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Chronic lymphocytic leukemia	21049055	CNVD
Cancer	21183584	CNVD
Honadal dysgenesis	21048976	CNVD
Neurodevelopmental disorder	22521361	CNVD
Endometrial cancer	23636398	CNVD
Disorders of sex development	21048976	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
Gastric cancer	21811585	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Multiple myeloma	17550852	CNVD
Lung cancer	18438408	CNVD
Glioma	17123091	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Lung cancer	21569311	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:133 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:35836800-35848000	Weak transcription	Brain Substantia Nigra	brain
2	chr19:35838200-35849200	Weak transcription	Brain Hippocampus Middle	brain
3	chr19:35839200-35848600	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
4	chr19:35839200-35848800	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
5	chr19:35840800-35846200	Active TSS	Pancreatic Islets	Pancreatic Islet
6	chr19:35840800-35848400	Weak transcription	Primary hematopoietic stem cells short term culture	blood
7	chr19:35843600-35846400	Enhancers	Primary neutrophils fromperipheralblood	blood
8	chr19:35843600-35847000	Enhancers	HepG2	liver
9	chr19:35843600-35848000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
10	chr19:35843800-35846400	Weak transcription	Adipose Nuclei	Adipose
11	chr19:35843800-35848600	Weak transcription	Gastric	stomach
12	chr19:35844000-35846800	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
13	chr19:35844000-35848400	Weak transcription	Primary T helper naive cells from peripheral blood	blood
14	chr19:35844000-35848800	Weak transcription	Primary hematopoietic stem cells	blood
15	chr19:35844000-35849000	Weak transcription	Ovary	ovary
16	chr19:35844000-35849000	Weak transcription	Spleen	Spleen
17	chr19:35844200-35846200	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
18	chr19:35844200-35846600	Weak transcription	Liver	Liver
19	chr19:35844200-35847200	Enhancers	GM12878-XiMat	blood
20	chr19:35844200-35848200	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
21	chr19:35844200-35848400	Weak transcription	Primary T helper cells PMA-I stimulated	--
22	chr19:35844200-35848400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
23	chr19:35844200-35848400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
24	chr19:35844200-35848800	Weak transcription	Primary T helper cells fromperipheralblood	blood
25	chr19:35844200-35849000	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
26	chr19:35844200-35849000	Weak transcription	Primary T killer memory cells from peripheral blood	blood
27	chr19:35844600-35847400	Weak transcription	Primary B cells from cord blood	blood
28	chr19:35844600-35849000	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
29	chr19:35844800-35846800	Weak transcription	Fetal Stomach	stomach
30	chr19:35845000-35846200	Weak transcription	Fetal Lung	lung
31	chr19:35845000-35848200	Weak transcription	Primary monocytes fromperipheralblood	blood
32	chr19:35845000-35848400	Weak transcription	Monocytes-CD14+_RO01746	blood
33	chr19:35846000-35846200	Bivalent Enhancer	Duodenum Mucosa	Duodenum
34	chr19:35846000-35846400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
35	chr19:35846200-35846400	Enhancers	Primary T killer naive cells fromperipheralblood	blood
36	chr19:35846200-35846400	Flanking Active TSS	Pancreatic Islets	Pancreatic Islet
37	chr19:35846200-35847200	Bivalent Enhancer	Placenta	Placenta
38	chr19:35846200-35847600	Enhancers	Fetal Lung	lung
39	chr19:35846400-35847000	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
40	chr19:35846400-35847200	Enhancers	Adipose Nuclei	Adipose
41	chr19:35846400-35847600	Weak transcription	Pancreatic Islets	Pancreatic Islet
42	chr19:35846400-35848200	Weak transcription	Primary neutrophils fromperipheralblood	blood
43	chr19:35846400-35848800	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
44	chr19:35846600-35847200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
45	chr19:35846600-35847200	Enhancers	Liver	Liver
46	chr19:35846800-35847000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
47	chr19:35846800-35847000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
48	chr19:35846800-35847200	Enhancers	Right Atrium	heart
49	chr19:35846800-35847400	Enhancers	Fetal Stomach	stomach
50	chr19:35846800-35847600	Enhancers	Fetal Adrenal Gland	Adrenal Gland

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links